The Biotechnology Innovation Organization (BIO) and the Council of State Bioscience Associations (CSBA) today released new data on the bioscience industry in the United States. The new report, The U.S ...

Explore these heartfelt and inspiring videos that explore how biotechnology uses “Nature’s Building Blocks” to create solutions to our greatest challenges: sustainability, health, and inequality. Each ...

This course features the most robust evidence, best practices, and guiding principles. Content is based on DiMe-generated research and other high-quality sources such as relevant regulatory guidance.

Medical Device Approval Primer takes a close look at the complex world of regulatory approval pathways. With a focus on the FDA and EMA agencies, it identifies the regulatory compliance requirements ...

DNA-Based Diagnostics Primer is the ultimate guide to the molecular science behind standard diagnostic tools used in research and clinical settings. This primer breaks down the critical technology ...

Diagnostics' Role in Medicine Today introduces the ever-expanding molecular diagnostics industry. This class defines the groundbreaking field of qualitative and quantitative biomarker measurements.

Diagnostic Measurements Primer unravels the importance of direct and indirect measurements and their vital role in obtaining regulatory approval. This class begins with the art of constructing and ...

Today, the Biotechnology Innovation Organization (BIO) and the Council of State Bioscience Associations (CSBA) released new national and state-level data on the U.S. bioscience industry's economic ...

John Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement regarding the resignation of Peter Marks from the FDA: “Under the extraordinary ...

“Most favored nation is a deeply flawed proposal that would devastate our nation’s small- and mid-size biotech companies – the very companies that are the leading drivers of medical innovation in the ...

BIO President & CEO John F. Crowley announced today that BIO would take several important steps to reaffirm the organization’s position with regards to national security and the role that the industry ...

The Biotechnology Innovation Organization (BIO) today released a new report examining antibacterial innovation and the current pipeline for new antibacterial medicines, The State of Innovation in ...